Circulating microRNA expressions can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma

TY - JOUR

T1 - Circulating microRNA expressions can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma

AU - Jung, Seung Hyun

AU - Lee, Sung Eun

AU - Lee, Minho

AU - Kim, So Hee

AU - Yim, Seon Hee

AU - Kim, Tae Woo

AU - Min, Chang Ki

AU - Chung, Yeun Jun

N1 - Funding Information: Departments of 1Cancer Evolution Research Center; 2Precision Medicine Research Center; 3Hematology, Seoul St. Mary's Hospital; 4Integrated Research Center for Genome Polymorphism; 5Leukemia Research Institute and 6Microbiology, College of Medicine, The Catholic University of Korea, Seoul, South Korea Funding: this study was supported by a grant from the Ministry for Health and Welfare (HI12C0129040016) and National Research Foundation of Korea (2012R1A5A2047939). Correspondence: [email protected]/[email protected] doi:10.3324/haematol.2017.168070 Information on authorship, contributions, and financial & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org.

PY - 2017/10/27

Y1 - 2017/10/27

UR - https://www.scopus.com/pages/publications/85032683183

U2 - 10.3324/haematol.2017.168070

DO - 10.3324/haematol.2017.168070

M3 - Letter

C2 - 28775122

AN - SCOPUS:85032683183

SN - 0390-6078

VL - 102

SP - e456-e459

JO - Haematologica

JF - Haematologica

IS - 11

ER -